Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Urinary Bladder Neoplasms 1Rectal Neoplasms 1Melanoma 1Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Diagnosis, Computer-Assisted × Clear all
NCT06221397 2026-03-16

LEGIT_MC_EVCDA

AI Labs Group S.L

Completed
105 enrolled 15 charts
Dermatologic

Disease, Melanoma

NCT01821105 2016-03-02

2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
21 enrolled 5 charts
GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡